Testing Events

Testing Events

Let's bring testing straight to you

Reintegrate schools, nursing homes, and corporate businesses by bringing the ideal COVID-19 diagnostic testing solution to your organization.

Who do we work with?

Kahala Biosciences’ mission is to provide organization-based testing programs for customers that are essential or in high-contact areas.

Through consistent testing and symptom monitoring, we work with our customers to develop safe guidance rules and plans as the economy reopens from COVID-19.

Nursing Homes

Essential, high-exposure workers

Kahala Biosciences works with nursing homes to provide simple and easy testing solutions for both staff and residents. By tracking the test results for essential workers and people who live in high-burden areas, organizations are given the ability to immediately identify and isolate any outbreaks.

Corporate Offices & Businesses

Reintegrate the Workforce

Kahala’s digital health platform enables rapid results that can be accessible by any smartphone or digital device, bringing your office back safely with easy-to-access actionable data.


Back to In-person Education

As schools grapple with the challenge of reopening their classrooms to welcome students once again, safety for children and families remain top of mind. Through a continuous quality improvement system, Kahala Biosciences will help determine the level of active cases, identify what interventions work to mitigate the spread of the virus, and analyze the emotional response by students and staff toward testing and symptom monitoring.

The Challenge

It is too easy for people to forgo testing, putting their health, potentially their lives, at risk.


Healthcare professionals are required to prescribe the test, causing delays that result from chronic shortages of supplies and equipment, such as PPE, swabs, reagents, and test processing capacity


Long delays lead to non-actionable information and possibly, a false sense of security


Long wait times often cause tremendous anxiety, delaying test takers from getting back to their tasks.
Test quality is uncertain, leading people to question the authenticity and accuracy of results.


High overhead costs are associated with labs and healthcare professionals

5 Pillars of a Successful Testing Program

Reliable and Accurate Testing

CLIA Lab Affiliation

Health Care Providers

Personal Protective Equipment

24/7 Customer Support

Schedule your next testing event with Kahala Biosciences

Request more information about how we can work with your specific organization. Our flexible team has a range of experience working in different environments to host testing events.

Background on COVID-19 Viral & Antibody Testing

What is COVID19?

COVID-19 is caused by the SARS-CoV-2 virus. The virus, which can cause mild to severe respiratory illness, was first identified in Wuhan, China, and has now spread globally, including the United States. It likely spreads to others when a person shows signs or symptoms of being sick (e.g., fever, coughing, difficulty breathing, etc.). For the most up-to-date information on COVID19 please visit the CDC Coronavirus Disease 2019 (COVID-19) website: https://www.cdc.gov/COVID19.

What is the SARS-CoV-2 PCR (Viral) Test?

The test detects the presence of viral RNA (similar to DNA), the virus that causes COVID-19, in nasal and/or saliva specimens.

How are the test results interpreted?

A positive result means that the test was able to detect the presence of the viral RNA. It indicates that the virus is present within the person. This can have multiple meanings – it could mean that the patient is a carrier for the virus and is not displaying symptoms, or if the person has symptoms, it could mean that active disease (COVID-19) is present. The final possibility is that the patient has cleared the virus and there are remnant traces of the viral RNA that will clear over time.

A negative result means that the test did not detect the presence of viral RNA. While this may be reassuring, it must be remembered that negative results do not necessarily mean the person is in the clear. For example, it takes a few days for the virus to incubate to levels that can be detected by PCR technology, and so another may be required in a few days if clinically indicated.

What is serologic testing?

The test will involve obtaining a drop of blood via finger prick, with a lancet. The blood sample will be applied to a test cassette, which will return a result that is visually interpreted. The results indicate if certain antibody types (IgG or IgM) are detected, or if the test is invalid and needs to be repeated. As for any test, the sensitivity (ability to detect antibodies when present) and specificity (antibody detected by the test represents the true presence of the antibody) are not 100%.

How are the test results interpreted?

Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic test should be considered to rule out infection in these individuals.

Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.

Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.

Is there any risk?

The risks of the standard test finger include possible discomfort or other complications that can happen during sample collection or possible incorrect test result. The software program will require that you share information.